Clinical trial
Post Market Surveillance Study Evaluating the Operative Management of Anastomotic Bleeding by Means of an Adjunctive Application of BioFoam Surgical Matrix in Cardiovascular Surgery
NCT02164201 is registered in ClinicalTrials.gov with CryoLife Europa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Market Surveillance Study Evaluating the Operative Management of Anastomotic Bleeding by Means of an Adjunctive Application of BioFoam Surgical Matrix in Cardiovascular Surgery
- Lead sponsor
- CryoLife Europa
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- July 31, 2015
- Enrollment
- 75 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
aortic valve replacement, cardiovascular procedures, thoracic aortic aneurysm, type a aortic dissection